Stay updated on Lenvatinib and Pembrolizumab in HCC Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib and Pembrolizumab in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib and Pembrolizumab in HCC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Plain Language Summary added and page updated to Revision 3.4.2 with new dates; funding-status notice removed.
    Difference
    0.3%
    Check dated 2026-02-11T09:21:20.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and updated the site to revision v3.4.1. These changes are administrative and do not modify the trial details, eligibility criteria, endpoints, or study data.
    Difference
    0.2%
    Check dated 2026-02-04T05:52:26.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Show glossary is now displayed; Last Update Submitted that Met QC Criteria and Last Update Posted timestamps are displayed; No FEAR Act Data is shown and Revision indicator updated to v3.4.0. The previous items Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4 were removed.
    Difference
    0.1%
    Check dated 2026-01-28T04:15:47.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.4 added and Revision: v3.3.3 removed.
    Difference
    0.0%
    Check dated 2026-01-14T03:22:28.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The Locations section now lists a large number of trial sites across the United States, Canada, Australia, and many other countries, detailing states, provinces, and cities. This expands the geographic coverage of the LEAP-002 study.
    Difference
    2%
    Check dated 2025-12-23T21:36:15.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Publications description text was slightly revised from 'results of the study' to 'study results', and the page now lists Revision: v3.3.2 (replacing the previous v3.2.0).
    Difference
    0.0%
    Check dated 2025-11-25T11:00:28.000Z thumbnail image

Stay in the know with updates to Lenvatinib and Pembrolizumab in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib and Pembrolizumab in HCC Clinical Trial page.